Antiepileptic drug interactions - principles and clinical implications. - Wikidata - awgldk - TriplyDB

Antiepileptic drug interactions - principles and clinical implications.

Antiepileptic drug interactions - principles and clinical implications.

http://www.wikidata.org/entity/Q34402188

about

Early versus late antiepileptic drug withdrawal for people with epilepsy in remission Medical management of epileptic seizures: challenges and solutions Antiepileptic Drug Treatment in Children with Epilepsy A quick review of carbamazepine pharmacokinetics in epilepsy from 1953 to 2012 Low vitamin D levels are common in patients with epilepsy.Population pharmacokinetics modeling of oxcarbazepine to characterize drug interactions in Chinese children with epilepsy.The World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the biological treatment of bipolar disorders: update 2012 on the long-term treatment of bipolar disorder.Imepitoin as novel treatment option for canine idiopathic epilepsy: pharmacokinetics, distribution, and metabolism in dogs.Antiepileptic and Antidepressive Polypharmacy in Patients with Multiple Sclerosis.Simultaneous UPLC-MS/MS determination of antiepileptic agents for dose adjustment.Levetiracetam in the Treatment of Epileptic Seizures After Liver Transplantation Health care cost associated with the use of enzyme-inducing and non-enzyme-active antiepileptic drugs in the UK: a long-term retrospective matched cohort study Antiepileptic drugs: a consideration of clinical and biochemical outcome in patients with epilepsy.Prevalence of Different Combinations of Antiepileptic Drugs and CNS Drugs in Elderly Home Care Service and Nursing Home Patients in Norway Impact of perampanel on pharmacokinetics of concomitant antiepileptics in patients with partial-onset seizures: pooled analysis of clinical trials.Evaluation of current pharmacological treatment options in the management of Rett syndrome: from the present to future therapeutic alternatives.Patient-reported financial barriers to adherence to treatment in neurology.Safety aspects of antiepileptic drugs--focus on pharmacovigilance.Second-generation antiepileptic drugs and pregnancy: a guide for clinicians.Ideal characteristics of an antiepileptic drug: how do these impact treatment decisions for individual patients?Antiepileptic drug treatment in pregnancy: changes in drug disposition and their clinical implications.The role of reactive species in epileptogenesis and influence of antiepileptic drug therapy on oxidative stress Safety of topiramate for treating migraines.Advances in epilepsy treatment: lacosamide pharmacokinetic profile.Antiseizure, antidepressant, and antipsychotic medication prescribing in elderly nursing home residents.Pharmacokinetic variability of valproate in women of childbearing age.Pharmacological considerations in the use of stiripentol for the treatment of epilepsy.Amino Acid Promoieties Alter Valproic Acid Pharmacokinetics and Enable Extended Brain Exposure.Drug-Drug Interactions in Headache Medicine.Pharmacotherapy in epilepsy - does gender affect safety?CYP2C9, CYP2C19, ABCB1 genetic polymorphisms and phenytoin plasma concentrations in Mexican-Mestizo patients with epilepsy.Toxic epidermal necrolysis due to lamotrigine in a pediatric patient.Systematic integration of biomedical knowledge prioritizes drugs for repurposing.Statin medication in patients treated with antiepileptic drugs in Norway.Prevalence and patterns of anti-epileptic medication prescribing in the treatment of epilepsy in older adults with intellectual disabilities.Precision and Bias of Target-Controlled Prolonged Propofol Infusion for General Anesthesia and Sedation in Neurosurgical Patients.Eslicarbazepine acetate in epilepsies with focal and secondary generalised seizures: systematic review of current evidence.Randomized, double-blind, placebo-controlled phase 2 study of ganaxolone as add-on therapy in adults with uncontrolled partial-onset seizures.Effect of carbamazepine or phenytoin therapy on blood level of intravenously administered midazolam: a prospective cohort study.Population pharmacokinetics of lamotrigine in Indian epileptic patients.

P2860

Q24188166-6FB7761B-5A00-4148-8DCB-B43055C94D59 Q26766413-191D600B-9EF3-4C7F-9666-D0474F38EDA4 Q26781771-732E4ABB-F04C-41AA-A1EA-BD621C9795E6 Q30486339-3AFFBEF9-465A-4F57-8257-A4E973009694 Q34112172-19A5D332-2FDE-478F-9D51-CECC708573EE Q34295058-AB1E857C-4F60-4F3A-9069-74D93A35FE45 Q34649187-688FA750-E0E2-4714-A82B-B53ECF769E82 Q34795269-FE1F60CA-E8FE-40F7-BD5B-AA6D6CC07B03 Q35843867-88FAF681-A67B-4B6A-9F87-B61F8901372F Q36225438-7796F350-6F5F-4E7F-B5FE-5E738A25F571 Q36255864-EF7AB6FC-22E5-4D45-9407-3D6C43774A13 Q36321018-4CCB3BA1-8F2A-444C-85BF-DAC1F295ADAD Q36917807-ECC5D8E0-8CD6-4F77-844E-2C8C836C4396 Q37147349-AEA6526E-106D-4BE6-A8D6-0D85342AACD4 Q37149455-13977398-FF50-4371-B8A1-5316403679AE Q37213531-800764FA-4403-4DCA-BE84-535A9F5859CD Q37426903-FE78DF29-1382-433C-9F75-D6C56F067BAF Q37954227-063B1427-5C75-492D-981F-0E78682CB86F Q38014890-1C2BF680-B7F5-482C-B17B-00EA17556E67 Q38056165-E540E24A-8C29-47C5-9B92-64D6F5CBB5C2 Q38077586-4496DF4B-6244-400C-B184-D584A17104B4 Q38111374-1B61FE30-802D-4A15-A772-06D6C9EF14DD Q38237259-4C9272CB-78BD-40CE-A35A-C2EA5996EF68 Q38244248-E00B8F69-9FAE-4515-9098-A085C52B3F71 Q38380197-71283917-DE6C-46C2-A298-BA8595FD624C Q38612367-61D7F2AD-2CA8-47E9-A7E7-D2B98DABBA76 Q38738877-EAC201EF-5601-4E4C-AE0C-993DF432B6DE Q38758331-1D8AAD42-098D-4511-8064-077BB9989BEC Q38879057-42D05FF4-8B4A-4E85-86E9-F8A084A81A23 Q38933880-D37EFAA3-04AF-4F2C-9982-C76E551CA526 Q41631036-B211CC5C-40CE-4508-8FC5-BC356DF68878 Q42237204-FAA08BDD-5BA3-4853-8F0D-47CBA066BABF Q42255083-0FCDEEDF-2C07-4AC1-92EC-CB71725675F8 Q45877071-232A3030-6C0C-414E-BA5E-856C1A258EAC Q47191207-C52B1AB8-6CCF-435D-B99A-015E6D469EAB Q47213786-3912CEF3-B3AB-4DC6-B7D3-28EBBCA40997 Q47235722-06C329EC-A81F-4731-8F9D-7A85F7E5D0B0 Q47326787-01A2383C-8E83-46B0-B6B7-0E5AE15A5FFB Q47664067-6872BC4C-2904-4842-BC4A-A46A6DBC5455 Q47669676-CED9A26F-1A18-4E62-8B4B-F16FB7F262A8

P2860

Antiepileptic drug interactions - principles and clinical implications.

http://www.wikidata.org/entity/Q34402188

description

2010 nî lūn-bûn

@nan

2010 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Antiepileptic drug interactions - principles and clinical implications.

@ast

Antiepileptic drug interactions - principles and clinical implications.

@en

Antiepileptic drug interactions - principles and clinical implications.

@nl

type

label

Antiepileptic drug interactions - principles and clinical implications.

@ast

Antiepileptic drug interactions - principles and clinical implications.

@en

Antiepileptic drug interactions - principles and clinical implications.

@nl

prefLabel

Antiepileptic drug interactions - principles and clinical implications.

@ast

Antiepileptic drug interactions - principles and clinical implications.

@en

Antiepileptic drug interactions - principles and clinical implications.

@nl

P1433

Q34402188-9CB52D26-CD74-4218-843A-6BF7858D0A59

P1476

Q34402188-918B86B0-9D98-4ECA-9EC3-AB78B358D671

P2093

Q34402188-5D1A1281-1B84-42A9-B6D3-97B6F3CC1F34

Q34402188-9BA50747-14E3-4908-8E41-89EFA27C33F3

P2860

Q34402188-024C9A2F-46E6-45FB-A1A9-B2429E35E6B3

Q34402188-0504CCE2-D9E4-4173-99D1-7878DAE33301

Q34402188-07288634-B727-48EF-9A45-23483DE89E38

Q34402188-07C7B96D-0BF0-4D58-B97E-E1A1107437B0

Q34402188-0C2B08FD-D36D-4175-B77E-4FB8B1B6E58B

Q34402188-0F907956-7B43-45BA-B742-821B37D9BD68

Q34402188-0FDADBCC-48BB-43E3-85AC-00F6C05BC225

Q34402188-13033BEC-ADC8-4F43-8FD8-46E95307458A

Q34402188-1506346F-8111-48C8-B21B-E07E76317C28

Q34402188-2248A8EC-348D-4B92-91CA-5F55FDF1E9ED

P304

Q34402188-8AB9421E-3871-48A7-A57F-E082E21A64AA

P31

Q34402188-B21F6F65-ED86-4D64-9DBC-B016D827C858

P356

Q34402188-D3813D3B-F2B3-4314-A5CD-E2C2C192251E

P433

Q34402188-AA5A01D1-BC67-4B6F-BA1C-AFCC6D1165C0

P478

Q34402188-8AD1C9B0-47A1-4072-933E-23E11A27F7C8

P577

Q34402188-92B7114F-A94F-45CD-B943-ABE73E07506F

P5875

Q34402188-427A2BB9-2661-498A-9741-C5800B03F9D4

P698

Q34402188-BF9EAF32-F26E-4F03-847E-B14D324F3045

P932

Q34402188-781DC84F-B06B-4A90-9A75-5A9B4EED7D80

P356

157015910792246254

P1433

Current Neuropharmacology

P1476

Antiepileptic drug interactions - principles and clinical implications.

@en

P2093

Cecilie Johannessen Landmark

http://www.w3.org/2001/XMLSchema#string

Svein I Johannessen

http://www.w3.org/2001/XMLSchema#string

P2860

Modifications of antiepileptic drugs for improved tolerability and efficacy

Drug treatment of epilepsy in elderly people: focus on valproic Acid

Rufinamide for the adjunctive treatment of partial seizures in adults and adolescents: a randomized placebo-controlled trial

Stiripentol. A novel antiepileptic drug

Progress report on new antiepileptic drugs: a summary of the Eigth Eilat Conference (EILAT VIII)

Effect of stiripentol on carbamazepine plasma concentration and metabolism in epileptic children

Effects of antiepileptic comedication on levetiracetam pharmacokinetics: a pooled analysis of data from randomized adjunctive therapy trials.

Pharmacokinetic interactions of drugs with St John's wort.

Nitroso-urea-cisplatin-based chemotherapy associated with valproate: increase of haematologic toxicity.

Lacosamide: pharmacology, mechanisms of action and pooled efficacy and safety data in partial-onset seizures.

P304

254-267

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2174/157015910792246254

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

8

http://www.w3.org/2001/XMLSchema#string

P577

2010-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

50228033

http://www.w3.org/2001/XMLSchema#string

P698

21358975

http://www.w3.org/2001/XMLSchema#string

P932

3001218

http://www.w3.org/2001/XMLSchema#string